Rationale and design of Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY): A multicenter randomized trial
BACKGROUND: Shuxuening injection (SXNI), a multi-target cerebroprotectant, holds promise as adjuvant therapy to intravenous thrombolysis (IVT) in acute ischemic stroke (AIS), but its efficacy has not yet been established. AIM: The aim of this study was to present the rationale and design of the Shux...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wolters Kluwer Medknow Publications
2026-01-01
|
| Col·lecció: | Brain Circulation |
| Matèries: | |
| Accés en línia: | https://journals.lww.com/10.4103/bc.bc_65_25 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|